JP2023517275A5 - - Google Patents
Info
- Publication number
- JP2023517275A5 JP2023517275A5 JP2022544069A JP2022544069A JP2023517275A5 JP 2023517275 A5 JP2023517275 A5 JP 2023517275A5 JP 2022544069 A JP2022544069 A JP 2022544069A JP 2022544069 A JP2022544069 A JP 2022544069A JP 2023517275 A5 JP2023517275 A5 JP 2023517275A5
- Authority
- JP
- Japan
- Prior art keywords
- mol
- lipid
- lipids
- lipid nanoparticles
- peg2000
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP20152995.5 | 2020-01-21 | ||
| EP20152995 | 2020-01-21 | ||
| EP20152938 | 2020-01-21 | ||
| EP20152938.5 | 2020-01-21 | ||
| EP20179434.4 | 2020-06-11 | ||
| EP20179434 | 2020-06-11 | ||
| PCT/EP2021/051290 WO2021148511A1 (en) | 2020-01-21 | 2021-01-21 | Lipid nanoparticles |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023517275A JP2023517275A (ja) | 2023-04-25 |
| JP2023517275A5 true JP2023517275A5 (https=) | 2024-02-13 |
Family
ID=74215945
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022544069A Pending JP2023517275A (ja) | 2020-01-21 | 2021-01-21 | 脂質ナノ粒子 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20230067722A1 (https=) |
| EP (1) | EP4093373A1 (https=) |
| JP (1) | JP2023517275A (https=) |
| KR (1) | KR20230002300A (https=) |
| CN (1) | CN115697298A (https=) |
| AU (1) | AU2021211894A1 (https=) |
| BR (1) | BR112022013837A2 (https=) |
| CA (1) | CA3168696A1 (https=) |
| IL (1) | IL294624A (https=) |
| MX (1) | MX2022009018A (https=) |
| TW (1) | TW202139975A (https=) |
| WO (1) | WO2021148511A1 (https=) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2020182993A1 (en) * | 2019-03-13 | 2020-09-17 | Etherna Immunotherapies Nv | Mrna vaccine |
| WO2022115645A1 (en) | 2020-11-25 | 2022-06-02 | Akagera Medicines, Inc. | Lipid nanoparticles for delivery of nucleic acids, and related methods of use |
| EP4346901A4 (en) * | 2021-06-01 | 2025-04-23 | The University of British Columbia | MRNA DELIVERY USING LIPID NANOPARTICLES |
| CA3238764A1 (en) * | 2021-11-23 | 2023-06-01 | Siddharth Patel | A bacteria-derived lipid composition and use thereof |
| CN114716355B (zh) * | 2022-04-02 | 2023-09-05 | 华南理工大学 | 一种脂质化合物、包含其的组合物及应用 |
| CN115887674B (zh) * | 2022-04-29 | 2023-08-25 | 北京剂泰医药科技有限公司 | 脂质纳米颗粒 |
| CA3256897A1 (en) | 2022-05-25 | 2023-11-30 | Akagera Medicines, Inc. | Lipid nanoparticles for the administration of nucleic acids and their methods of use |
| CN115414476B (zh) * | 2022-08-15 | 2023-07-14 | 珠海暨创硒源纳米科技有限公司 | 一种改性氧化镁、含镁纳米颗粒水溶液及其制备方法与在制备佐剂中的应用 |
| WO2024064206A1 (en) * | 2022-09-20 | 2024-03-28 | Emory University | Lipid nanoparticles comprising nucleic acids encoding therapeutic genes and uses in medical methods |
| CN116763756A (zh) * | 2022-10-11 | 2023-09-19 | 中国科学院化学研究所 | 一种脂质纳米颗粒及其制备方法和应用 |
| JP7813825B2 (ja) * | 2023-02-07 | 2026-02-13 | 株式会社微生物化学研究所 | ワクチン |
| CN115998714B (zh) * | 2023-03-20 | 2023-06-30 | 威瑞生物科技(昆明)有限责任公司 | 一种脂质纳米颗粒、递送系统及递送系统的制备方法 |
| EP4442256A1 (en) | 2023-04-04 | 2024-10-09 | Københavns Universitet | Lipid nanoparticle compositions |
| AU2024279278A1 (en) | 2023-05-31 | 2025-12-18 | Capstan Therapeutics, Inc. | Lipid nanoparticle formulations and compositions |
| CN117159492A (zh) * | 2023-07-27 | 2023-12-05 | 广州制高点医药科技有限公司 | 一种含有唾液酸脂质衍生物的脂质纳米颗粒及其应用 |
| CN120359024A (zh) | 2023-10-12 | 2025-07-22 | 科百博生物股份有限公司 | 脂质纳米颗粒 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20110305769A1 (en) * | 2008-11-17 | 2011-12-15 | Enzon Pharmaceuticals, Inc. | Branched cationic lipids for nucleic acids delivery system |
| EP3243504A1 (en) * | 2009-01-29 | 2017-11-15 | Arbutus Biopharma Corporation | Improved lipid formulation |
| KR101766408B1 (ko) * | 2009-06-10 | 2017-08-10 | 알닐람 파마슈티칼스 인코포레이티드 | 향상된 지질 조성물 |
| ES2795110T3 (es) * | 2011-06-08 | 2020-11-20 | Translate Bio Inc | Lípidos escindibles |
| AU2014340149B2 (en) * | 2013-10-22 | 2020-12-24 | Shire Human Genetic Therapies, Inc. | CNS delivery of mRNA and uses thereof |
| HUE058792T2 (hu) | 2013-11-12 | 2022-09-28 | Univ Brussel Vrije | RNS-transzkripciós vektor és felhasználása |
| EP3247398A4 (en) * | 2015-01-23 | 2018-09-26 | Moderna Therapeutics, Inc. | Lipid nanoparticle compositions |
| PL3386484T3 (pl) * | 2015-12-10 | 2022-07-25 | Modernatx, Inc. | Kompozycje i sposoby dostarczania środków terapeutycznych |
| US11458106B2 (en) * | 2016-05-09 | 2022-10-04 | Astrazeneca Ab | Lipid nanoparticles comprising lipophilic anti-inflammatory agents and methods of use thereof |
| WO2017218704A1 (en) * | 2016-06-14 | 2017-12-21 | Modernatx, Inc. | Stabilized formulations of lipid nanoparticles |
| CN109563511A (zh) * | 2016-06-30 | 2019-04-02 | 阿布特斯生物制药公司 | 用于递送信使rna的组合物和方法 |
| WO2018175783A1 (en) * | 2017-03-22 | 2018-09-27 | Modernatx, Inc. | Rna bacterial vaccines |
| EP3733647B1 (en) * | 2017-12-27 | 2022-06-15 | Eisai R&D Management Co., Ltd. | Cationic lipid |
| CA3088485A1 (en) * | 2018-01-18 | 2019-07-25 | Etherna Immunotherapies Nv | Lipid nanoparticles |
-
2021
- 2021-01-21 EP EP21701492.7A patent/EP4093373A1/en active Pending
- 2021-01-21 BR BR112022013837A patent/BR112022013837A2/pt unknown
- 2021-01-21 IL IL294624A patent/IL294624A/en unknown
- 2021-01-21 TW TW110102316A patent/TW202139975A/zh unknown
- 2021-01-21 US US17/794,087 patent/US20230067722A1/en active Pending
- 2021-01-21 JP JP2022544069A patent/JP2023517275A/ja active Pending
- 2021-01-21 CA CA3168696A patent/CA3168696A1/en active Pending
- 2021-01-21 CN CN202180010449.4A patent/CN115697298A/zh active Pending
- 2021-01-21 AU AU2021211894A patent/AU2021211894A1/en active Pending
- 2021-01-21 KR KR1020227028916A patent/KR20230002300A/ko active Pending
- 2021-01-21 MX MX2022009018A patent/MX2022009018A/es unknown
- 2021-01-21 WO PCT/EP2021/051290 patent/WO2021148511A1/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023517275A5 (https=) | ||
| CN113185421B (zh) | 脂质化合物及其组合物 | |
| CN114149337B (zh) | 一种用于核酸递送的新型可电离脂质及其lnp组合物 | |
| TWI699354B (zh) | 陽離子性脂質 | |
| JP2022535006A (ja) | 増殖ｔ細胞アッセイ | |
| US8945529B2 (en) | Biphasic lipid-vesicle compositions | |
| US20070066552A1 (en) | Topical administration permitting prolonged exposure of target cells to therapeutic and prophylactic nucleic acids | |
| JP2021511376A (ja) | 脂質ナノ粒子 | |
| JP2025503982A (ja) | カチオン性脂質類似体、その組成物および使用 | |
| JP2021502346A (ja) | 生物学的活性分子を送達するための融合性化合物 | |
| JPWO2008143339A1 (ja) | 両親媒性分子、それを含む分子集合体及びその用途 | |
| JP5588619B2 (ja) | ｐＨ応答性リポソーム | |
| Ahmad et al. | Liposomes and niosomes for targeted drug and gene delivery systems | |
| CN117964577B (zh) | 阳离子脂质化合物、其制备方法、包含其的组合物及应用 | |
| WO2024140893A1 (zh) | 一种类固醇-阳离子脂质化合物及其应用 | |
| WO2023143591A1 (zh) | 一种用于核酸递送的新型可电离脂质及其lnp组合物和疫苗 | |
| CN115487168A (zh) | 一种基于含氮杂环胆固醇衍生物的脂质纳米颗粒及其应用 | |
| JPWO2022244815A5 (https=) | ||
| US20210196836A1 (en) | Formulation of nanostructured gels for increased agent loading and adhesion | |
| JP2023514951A (ja) | 脂質化合物及びその組成物 | |
| CN120349253A (zh) | 一种可电离脂质化合物及其应用 | |
| US12064512B2 (en) | Silyl lipids suitable for enhanced delivery of anti-viral therapeutics | |
| CN117417264B (zh) | 氨基脂质化合物、其制备方法和应用 | |
| WO2024009316A1 (en) | Cationic lipid based composition, formulation and use for nucleic acid vaccine delivery and preparation thereof | |
| WO2024149303A1 (zh) | 一种类固醇-阳离子脂质化合物及其应用 |